Day: November 5, 2025

USFDA Approves GSK’s Blenrep for Relapsed/Refractory Multiple Myeloma, Showing Superiority Over Daratumumab-based Regimen image
2 min read

USFDA Approves GSK’s Blenrep for Relapsed/Refractory Multiple Myeloma, Showing Superiority Over Daratumumab-based Regimen

Pharm'Up
GSK plc has announced that the US Food and Drug Administration (FDA) has granted approval for Blenrep...
Read More Read more about USFDA Approves GSK’s Blenrep for Relapsed/Refractory Multiple Myeloma, Showing Superiority Over Daratumumab-based Regimen
Mazdutide, a Dual GLP-1/GCG Agonist, Demonstrates Superiority Over Semaglutide in Glycemic Control and Weight Loss for Type 2 Diabetes Patients image
2 min read

Mazdutide, a Dual GLP-1/GCG Agonist, Demonstrates Superiority Over Semaglutide in Glycemic Control and Weight Loss for Type 2 Diabetes Patients

Pharm'Up
Innovent Biologics announced that its fourth Phase 3 clinical trial, DREAMS-3, evaluating the novel drug mazdutide in...
Read More Read more about Mazdutide, a Dual GLP-1/GCG Agonist, Demonstrates Superiority Over Semaglutide in Glycemic Control and Weight Loss for Type 2 Diabetes Patients
Merck’s Combo Therapy KEYTRUDA + WELIREG Hits Primary Endpoint in Kidney Cancer Adjuvant Trial (LITESPARK-022) image
2 min read

Merck’s Combo Therapy KEYTRUDA + WELIREG Hits Primary Endpoint in Kidney Cancer Adjuvant Trial (LITESPARK-022)

Pharm'Up
Merck (known as MSD outside North America) has announced positive top-line results from its Phase 3 LITESPARK-022...
Read More Read more about Merck’s Combo Therapy KEYTRUDA + WELIREG Hits Primary Endpoint in Kidney Cancer Adjuvant Trial (LITESPARK-022)
Teva Settles QVAR Antitrust Case for $35 Million and Agrees to Withdraw Patents, Resolving Generic Delay Claims image
2 min read

Teva Settles QVAR Antitrust Case for $35 Million and Agrees to Withdraw Patents, Resolving Generic Delay Claims

Pharm'Up
Teva Pharmaceuticals USA, Inc., has agreed to a $35 million settlement to resolve a class action lawsuit...
Read More Read more about Teva Settles QVAR Antitrust Case for $35 Million and Agrees to Withdraw Patents, Resolving Generic Delay Claims
Researchers Uncover ‘Perineural Pathway’ Allowing HIV to Escape the Brain and Reseed the Body Despite Antiretroviral Therapy image
2 min read

Researchers Uncover ‘Perineural Pathway’ Allowing HIV to Escape the Brain and Reseed the Body Despite Antiretroviral Therapy

Pharm'Up
New research published in The American Journal of Pathology by investigators from Boston College and the Tulane...
Read More Read more about Researchers Uncover ‘Perineural Pathway’ Allowing HIV to Escape the Brain and Reseed the Body Despite Antiretroviral Therapy
FDA Moves to Ban Unapproved Fluoride Pills and Drops for Children, Citing Microbiome Risk and Outdated Science image
2 min read

FDA Moves to Ban Unapproved Fluoride Pills and Drops for Children, Citing Microbiome Risk and Outdated Science

Pharm'Up
The U.S. Food and Drug Administration (FDA) has announced a major policy shift, taking action to restrict...
Read More Read more about FDA Moves to Ban Unapproved Fluoride Pills and Drops for Children, Citing Microbiome Risk and Outdated Science

Read These Too

Pharmup 21
2 min read

Understanding Small Intestine Cancer: Risks, Symptoms, and Treatment

Pharm'Up
Pharmup 20
2 min read

Infant Reflux (GER) and GERD: Spitting Up and Growth

Pharm'Up
Pharmup 19
2 min read

Understanding Reflux (GER) and GERD in Children

Pharm'Up
Pharmup 18
2 min read

Gastroenteritis: Understanding the “Stomach Bug” and Food Poisoning

Pharm'Up